Essence Investment AG ("Essence" or the "Company"), a leading Swiss holding supporting the growth of the European cannabis industry, today announced the acquisition on 30 December 2022 of a 100% stake in AMP Alternative Medical Products GmbH ("AMP"), a German-licensed importer and distributor of EU-GMP medical cannabis products.